Free Trial

Repare Therapeutics (RPTX) Competitors

Repare Therapeutics logo
$1.37 -0.07 (-4.86%)
Closing price 07/3/2025 01:26 PM Eastern
Extended Trading
$1.38 +0.01 (+0.66%)
As of 07/3/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPTX vs. ACB, NGNE, TVRD, BTMD, SLRN, TVGN, CGC, PRQR, NBTX, and YMAB

Should you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Aurora Cannabis (ACB), Neurogene (NGNE), Tvardi Therapeutics (TVRD), biote (BTMD), Acelyrin (SLRN), Semper Paratus Acquisition (TVGN), Canopy Growth (CGC), ProQR Therapeutics (PRQR), Nanobiotix (NBTX), and Y-mAbs Therapeutics (YMAB). These companies are all part of the "pharmaceutical products" industry.

Repare Therapeutics vs. Its Competitors

Repare Therapeutics (NASDAQ:RPTX) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

Aurora Cannabis has a net margin of 1.32% compared to Repare Therapeutics' net margin of 0.00%. Aurora Cannabis' return on equity of 0.13% beat Repare Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Repare TherapeuticsN/A -78.12% -67.11%
Aurora Cannabis 1.32%0.13%0.10%

In the previous week, Repare Therapeutics had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Repare Therapeutics and 2 mentions for Aurora Cannabis. Repare Therapeutics' average media sentiment score of 0.00 beat Aurora Cannabis' score of -0.12 indicating that Repare Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Repare Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aurora Cannabis has higher revenue and earnings than Repare Therapeutics. Repare Therapeutics is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Repare Therapeutics$53.48M1.10-$84.69M-$3.01-0.46
Aurora Cannabis$246.72M1.04$1.63M$0.1141.59

85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 11.5% of Repare Therapeutics shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Repare Therapeutics has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500.

Repare Therapeutics presently has a consensus price target of $4.50, suggesting a potential upside of 228.47%. Given Repare Therapeutics' higher possible upside, analysts plainly believe Repare Therapeutics is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Repare Therapeutics
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67

Summary

Aurora Cannabis beats Repare Therapeutics on 9 of the 16 factors compared between the two stocks.

Get Repare Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPTX vs. The Competition

MetricRepare TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$61.76M$2.92B$5.56B$9.05B
Dividend YieldN/A2.44%5.24%3.99%
P/E RatioN/A8.2819.9620.26
Price / Sales1.10283.26419.56119.26
Price / CashN/A41.7026.2128.59
Price / Book0.387.538.035.65
Net Income-$84.69M-$55.14M$3.18B$249.15M
7 Day Performance-1.44%4.61%2.93%3.28%
1 Month Performance-6.80%0.90%1.72%3.95%
1 Year Performance-56.78%5.40%34.39%20.98%

Repare Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPTX
Repare Therapeutics
2.1022 of 5 stars
$1.37
-4.9%
$4.50
+228.5%
-56.8%$61.76M$53.48M0.00180News Coverage
ACB
Aurora Cannabis
0.1956 of 5 stars
$4.24
+2.2%
N/A-5.1%$233.29M$246.72M38.551,130
NGNE
Neurogene
3.8085 of 5 stars
$14.95
-7.5%
$46.17
+208.8%
-41.3%$230.48M$930K-3.4490News Coverage
Positive News
TVRD
Tvardi Therapeutics
N/A$23.33
-5.2%
$71.50
+206.5%
N/A$230.37M$7.14M0.0080
BTMD
biote
3.0897 of 5 stars
$4.02
-4.3%
$8.00
+99.0%
-43.0%$229.78M$197.19M6.59194News Coverage
Positive News
SLRN
Acelyrin
N/A$2.27
flat
$9.60
+322.9%
N/A$229.17MN/A-0.92135
TVGN
Semper Paratus Acquisition
3.9852 of 5 stars
$1.25
+0.8%
$10.00
+700.0%
+77.9%$228.03MN/A0.003Positive News
CGC
Canopy Growth
2.8387 of 5 stars
$1.22
flat
$2.00
+63.9%
-79.6%$224.32M$225.65M-0.303,150Positive News
PRQR
ProQR Therapeutics
2.1281 of 5 stars
$2.04
flat
$8.00
+292.2%
+26.1%$214.63M$20.46M-5.83180News Coverage
NBTX
Nanobiotix
1.6861 of 5 stars
$4.73
+4.4%
$8.00
+69.1%
-8.2%$213.34M$39.18M0.00100Positive News
Gap Up
YMAB
Y-mAbs Therapeutics
3.1314 of 5 stars
$4.51
-4.0%
$15.60
+245.9%
-62.2%$212.83M$87.68M-7.05150News Coverage

Related Companies and Tools


This page (NASDAQ:RPTX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners